INSTITUTE OF COMMUNICATION
& COMPUTER SYSTEMS
The Institute of Communications and Computer Systems (ICCS) is associated with the School of Electrical and Computer Engineering (SECE) of the National Technical University of Athens (NTUA) and is being supervised by the Hellenic Ministry of Education.
ICCS is a non-profit Academic Research Body established in 1989, and since its foundation it carries out research and development activities in the fields of all diverse aspects of telecommunications, computer systems and techniques and their application in almost all areas of advanced technological research and innovation. It is the most active Academic Research Institute in the country, involving 13 Research Units, 28 Laboratories, more than 120 Faculty members and Research Scientists and more than 500 Associate Scientists (including Ph.D. students).
ICCS is very active in European co-funded research activities and has been partner, technical director or coordinator of hundreds of EU projects in various programs over the years (e.g. EC, ISIS, RACE II, ESPRIT, IES, ACTS, INFOSEC, BRITE-EURAM, STRIDE, MIP-Informatics, Telematic Applications, IST, GROWTH, QoL, JOULE, ENERGIE, FP6, FP7, HORIZON, Marie Curie, etc.).
In RETENTION, ICCS participates with the Biomedical Engineering Lab, operating in the Institute’s framework. The Biomedical Engineering Laboratory (BEL), legally established within the School of Electrical and Computer Engineering of NTUA, operates since 1990. BEL had the presidency of E-Health Forum 2014, which was organized under the auspices of the Greek EU Presidency in cooperation with the European Commission, and was one of the founders of HL7 Hellas. Its activities cover a wide range of Basic and Applied Research in specialised Biomedical Engineering fields, focusing on the development of applicable end-products.
The main research areas of BEL’s expertise include: Medical Data Management Systems, Medical Informatics, Telemedicine, Bio-signal and Medical Image processing, Biosensors, Augmented Reality in Medicine and Healthcare, Neural Networks in Medical Applications, Clinical Decision Support Systems, Data Fusion Algorithms, but also SOA Architecture, Web services and Interoperability Standards as well as Home Care Systems and Services and e-Health Applications in general.
ONASSIS CARDIAC SURGERY CENTER
Onassis Cardiac Surgery Center (O.C.S.C.), is a tertiary hospital, located in Athens, Greece and specializing in cardiovascular surgery and in diagnostic and interventional cardiology. It was designed, built, equipped and furnished by the “Alexander S. Onassis” Public Benefit Foundation (www.onassis.gr) started operating in 1993.
It operates under the supervision of the Greek Ministry of Health as a non-for-profit institution and deals with all types and severity of medical problems of the heart. Its activities span from simple diagnostic tests to the most sophisticated and complex heart operations, artificial heart implantation and heart transplantation.
OCSC performs, on a yearly basis, about 2.100 open-heart operations (CABG, Valves, Aneurysms, combined surgeries, redos, etc), about 12-15 heart transplantations, about 10-15 VAD (artificial heart) implantations and about 5.500 heart catheterization procedures (angioplasty, STENTS, valvuloplasty, TAVI, interventional electrophysiology, defibrillators and pacemakers implantations, etc), covering about 30%-50% of the Greek activities of this sector (100% in heart transplantations).
Especially for heart transplants, OCSC runs the only active transplantation program in Greece and is the only authorized hospital in which heart transplantations are taking place in the country. Recently, a special Lung Transplantation programme was initiated in OCSC, the only one in Greece.
A special Pediatrics Dept. deals with congenital heart problems of children (0-18 years old), both for cardiology and cardiac-surgery. OCSC also specializes in heart failure (HF) from the very early stages up to heart assist devices implantation (artificial heart – Left/Right/Both Ventricular Assist Device/VAD), to heart transplantation and to the post-operative management of transplanted patients. In its 22 years of operation, OCSC has a very rich registry of patients of almost every type and variety of heart disease.
Amongst them, particular interest, both in clinical and financial/social terms, has been the group of patients with heart failure (HF), and especially the later stages of the disease (VAD implantation, heart transplantation), on which this proposal is focused.
ALMA MATER STUDIORUM
UNIVERSITA’ DI BOLOGNA
The Alma Mater Studiorum, the oldest university in the Western world, paves the way for innovation through an increasingly rich programme catalogue, cutting-edge research and a constant and increasingly broad international perspective. Since its origins in 1088, Alma Mater has been student-centred, hosting prominent figures from science and the arts.
Based in five campuses (Bologna, Cesena, Forlì, Ravenna, Rimini), with a branch in Buenos Aires, it offers a teaching catalogue diversified and tailored to the needs of present-day society: over 200 degree programmes among its 32 Departments and 11 Schools are offered to over 81,000 students. 5,000 graduates are enrolled in PhDs and 3rd cycle programmes. As a comprehensive research university, Alma Mater invests in the multidisciplinary cross-cultural approach and in the inseparable connection between research and teaching.
One of the most active universities leading and participating in European research and academic cooperation projects, Bologna has formed knowledge alliances with industry and public/private organizations. It is a hub of international networks. Beyond its close European links, it enjoys multiple connections with America, Africa, Asia and Australia. Research and Innovation are a priority of the University mission.
With regard to Innovation, UNIBO filed 86 new patent applications in 2017, of which 25 are new registrations, thereby giving rise to an active patent portfolio of over 370 patents related to more than 140 inventions. It also has an active portfolio of more than 20 patented plant varieties, 80% of which are increased in value through active licenses with geographic coverage in countries in different parts of the world. UNIBO set up or accredited 27 spin-off companies up to 2017 and can also count Almacube, as a business incubator that managed 15 incubated companies in 2017. With regard to the capability of attracting funding for research and innovation, UNIBO is very active both at National and European level in all the research areas.
Activities related to competitive funding programs are supported by the Research and Third Mission Division, with more than 10 years’ experience and about 50 people assisting the research groups in the whole project lifecycle. A Research Development Office deals with the UNIBO strategic positioning at local, national and international level, through integrated networking and lobby activities in each specific research area. While the Programs & Projects Office supports the UNIBO researchers from the proposal submission to the implementation phase of the projects with technical, legal, financial and administrative expertise.
These Offices strictly cooperate between each other and in strictly connection with the Knowledge Transfer Office, for the Innovation Management expertise and the IP protection and exploitation, and the take up and commercialization of project results. Thanks to its scientific excellence and a central Project Management support working closely, UNIBO has gained a considerable experience in International and European research projects, successfully participated in FP7: with 274 projects funded in 2007-2013 (58 of them as coordinator) and 87,8 M€ of funding, UNIBO is the second Italian university for the attractiveness of European funding for research, 37st in the European ranking of institutions of higher education.
In Global Rankings UNIBO occupies the top 10 national rank in major league tables such as QS World University Rankings, THE World University Rankings, ARWU World University Rankings. In 2017 it ranked 29 in the GreenMetric World University Rankings measuring the university’s vision and policy for sustainability. In Horizon 2020, UNIBO is so far involved in 262 funded projects (69 as coordinator).
UNIVERSITY HOSPITAL ESSEN
The University Hospital Essen (UK Essen) is the largest university hospital for first-rate medical services in the Ruhr region of Germany, with 8 million inhabitants, the most population-dense region in Europe. The Medical School and Medical Faculty is located on campus and is part of the University of Duisburg- Essen, one of the youngest and largest universities in Germany with more than 42,000 students in 11 faculties.
The UDE’s Faculty of Medicine and the University Hospital Essen form the core academic medical centre of the Ruhr area with 25 institutes and 33 clinics. The faculty was founded in 1963 and is dedicated to national and international excellence in cardiovascular medicine, oncology, transplantation medicine, immunology/infectiology and neuro- & behavioural sciences. In 2019, the U.S. News “Best Global Universities Ranking” ranked the Medical Education top 100 worldwide (“Best Global Universities for Clinical Medicine”).
In the same evaluation the Faculty´s Cardiology ranked at place 58 worldwide in “top global universities for cardiac and cardiovascular systems”. The recent report of the Wissenschaftsrat (German Council of Science and Humanities) particularly highlighted the success of the two key research areas oncology as well as immunology and infectiology.
PI groups from Essen benefit from an excellent infrastructure on campus, including modern research labs in the Medizinisches Forschungszentrum (medical science center), opened in 2012 in direct proximity to the clinical departments, small and large animal houses with a behavioural unit, small animal PET-CT, large animal operating theatre, a clinical trial unit, automated large scale biobanking (DFG funded West German Biobank), genomics core facility, the cutting-edge imaging unit IMCES, the clinical chemistry research division, a centre for clinical studies in Essen, a BioChip Laboratory and a DNA Sequencing Facility.
Researchers at the UK Essen are supported by the Faculty’s research consultant, closely cooperating with the Universities Science Support Center with technical, legal, financial and administrative expertise. In addition, there are several incentive programs directly funded by the Dean’s office, to support and honor research activities and to support young- and female investigators during career development.
The medical faculty of the University Duisburg-Essen and the university hospital Essen have a strong commitment to career development of young clinician and basic scientists in medical research. PhD students enrol in the interdisciplinary, globally-focused Graduate School of Biomedical Science, currently comprising four DFG funded research training groups and nine topical BIOME cores. Physicians will have the opportunity to participate in the faculty’s structured, DFG-funded clinician scientist program, the University Medicine Essen Clinician Scientist Academy (UMEA). This 3-year program offers protected research time in combination with a dedicated qualification concept, mentoring and scientific events. Notably, endorsement of structured career programs for clinician scientists has recently been granted by the Medical Council North Rhine (Ärztekammer Nordrhein), with credit of up to 18 months of research time towards specialist residency training.
One key aim of the University Hospital Essen is to continuously develop and enhance the concept of a “Smart Hospital”. Significant efforts have already and will be made to improve modern treatments as well as implementation of all technical aspects to provide best medical care and safety to patients by providing every tool of technology, such as telemedicine etc.
SERVICIO MADRILEÑO DE SALUD
Servicio Madrileño de Salud (SERMAS) is the administrative and management structure that integrates every public hospital and other public health services of the Madrid Regional Health System.
It is the legal representative (beneficiary) of the two public hospitals contributing to RETENTION and has delegated authority to the relevant Hospital Foundations which will handle the financial and administrative aspects of the Hospital’s involvement in the project.
There are two hospitals participating in RETENTION under the same beneficiary: Hospital Universitario Ramón y Cajal (SERMAS-HURYC) and Hospital Universitario Puerta de Hierro Majadahonda (SERMAS-HUPHM).
Hospital Universitario Ramón y Cajal (SERMAS-HURC)
Hospital Universitario Ramón y Cajal is a 1,000-bed university hospital in Madrid founded in 1977, affiliated to Universidad de Alcalá and part of the Servicio Madrileño de Salud (SERMAS). It provides comprehensive health care in all medical and surgical specialties, and it includes an established research institute: Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), which encompasses basic, translational and clinical research departments. The institute has all the required infrastructures to perform phase I to IV clinical trials, including full laboratory and imaging equipment and an ethical committee.
It ranks first in Madrid and third in Spain in production of biomedical research, working in partnership with more than 50 international leading centres. SERMAS-HURYC consists of 39 research groups that focus their activities on five major areas: neurosciences; microbiology, immunology and infection; chronic diseases and cancer; epidemiology and health technology; cardio-metabolism and systems pathology. It also hosts many other independent researchers from the clinical area.
All this critical mass generates +1000 publications and 200 new clinical trials per year. The knowledge created by all this activity has resulted in more than 80 innovation projects, and 25 patent families. SERMAS-HURYC has a business development office, giving support to all projects from their very beginning, “from the idea to the market”; this office includes one innovation and technology transfer unit, certified by UNE 166002:2014, as well as one international projects unit.
Hospital Universitario Puerta de Hierro (SERMAS-HUPHM) It began its activities in 1964 and the main goals that underpin its creation are still present today: Clinical activities, Research, Development and Innovation and Clinical training.
The HUPHM has a useful surface of 165,000 m2, structured in 3 areas: Doctors’ Offices; Hospitalization Unit and Labs and Research Area. In this way, the Hospital also has: 613 beds, 62 outpatient care stations and 22 dialysis stations; 21 operating rooms and 2 rooms for experimental surgery; and 36 beds in the Emergency department.
HUPHM is currently a reference in communication and information technologies, due to the fact of having the most modern Information Technology Systems.
NATIONAL AND KAPODISTRIAN
UNIVERSITY OF ATHENS
The National and Kapodistrian University (NKUA) of Athens Medical School established in 1837, is the oldest and largest medical school in Greece. Attikon University Hospital is the latest and largest NKUA affiliated university hospital, covering a vast rural area in the capital’s region and accepting referrals from all over the country.
The Heart Failure Unit at Attikon University Hospital is a leading heart failure unit with a very busy in-patient and out-patient service and an extended clinical research portfolio. The Heart Failure Unit is accepting referrals from all over the country and abroad and participates in local, national and international research projects.
FOUNDATION FOR RESEARCH
AND TECHNOLOGY HELLAS
Foundation for Research and Technology Hellas (FORTH): FORTH established in 1983, is one of the largest research centers in Greece with well – organized facilities and highly qualified personnel. Over the years, FORTH has become one of the top European research centers, thanks to its high impact research results and its valuable socio economic contribution.
FORTH/IMBB: The Institute of Molecular Biology and Biotechnology (IMBB) is based in Heraklion (Crete), and is conducting basic and applied research in established and emerging areas of Biomedical science. IMBB was founded in 1983 and is part of the Foundation of Research and Technology-Hellas (FORTH), one of the largest research centers in Greece.
FORTH/IMBB-BR www.imbb.forth.grl & www.bri.forth.gr was founded in 1998, is the section of FORTH/IMBB focusing on biomedical research and is located in Ioannina, Greece. The work in this project will be implemented by the Unit of Medical Technology & Intelligent Information Systems (MedLab). MedLab is a highly innovative research unit working in the fields of Biomedical Engineering and development of Intelligent Information Systems.
LSE HEALTH, LONDON SCHOOL OF
ECONOMICS AND POLITICAL SCIENCE
The LSE is the leading European University in social sciences, including economics, social policy and health policy. LSE Health is a Research Centre located within the Department of Health Policy. The Department of Health Policy is devoted to excellence in multidisciplinary teaching, with an emphasis on health policy, health economics and management applied to the health sector.
Its mission is to influence and improve how health policy is designed, implemented and evaluated, and help to strengthen health policy governance around the world by applying LSE’s tradition of rigorous social science research to emerging national and global health challenges.
LSE Health’s fundamental mission is the production and dissemination of high-quality research in health care. The Centre’s unique research base contributes to LSE’s established world presence and reputation in health policy, health economics and demography.
It is one of the leading research centres with a strong policy focus based on evidence and measurement of performance across health systems and health services. Bringing together a core team of researchers and academics, LSE Health promotes and draws upon the multidisciplinary expertise of 38 staff members, 20 associated academics and a number of PhD students.
LSE Health has international experience and accumulated expertise on Pharmaceutical Policy, Health Technology Assessment; Medical Devices; and Health Systems Analysis and Reform, among others. It is a WHO Collaborating Centre in European Health Policy and Pharmaceutical Policy. It is a founding member of the European Observatory of Health Systems and Policies and it hosts one of its research hubs.
Sphynx Technology Solutions AG is based at Zug, Switzerland with branches in Cyprus and London. The company offers products and solutions, and consulting services, in the areas of cyber intelligence, analytics, incident response, assurance and certification. The technologies offered by Sphynx include sophisticated event processing and analytics, security monitoring and testing, intrusion detection, fraud management, and incident response. Sphynx deploys off-the-shelf hardware components along with its custom software to provide tools including its security audit and certification platform and its model-driven big data analytics platform.
The technologies offered by Sphynx include sophisticated event processing and analytics, security monitoring and testing, intrusion detection, fraud management, and incident response. Sphynx deploys off-the-shelf hardware components along with its custom software to provide tools including its security audit and certification platform and its model-driven big data analytics platform. Via its consulting services, Sphynx has expertise in providing customized solutions depending on client needs as well as more general training on analytics, security assessment and certification and cyber intelligence.
Via its consulting services, Sphynx has expertise in providing customized solutions depending on client needs as well as more general training on analytics, security assessment and certification and cyber intelligence.
Sphynx has significant expertise in cyber security solutions and cyber security and privacy assurance solutions. Its security and privacy assurance platform offers multiple and complementary types of analysis of cyber threats, vulnerabilities and operational security and privacy conditions based on static analysis, penetration testing and continuous monitoring, enabling both signature and anomaly based checks, of all levels of typical implementation stacks of cyber systems.
By virtue of being model driven, the security and privacy assurance platform of Sphynx offers high levels of automation and customisation to different security standards and organisations. Currently, Sphynx is also developing cyber range capabilities on the top of its security and privacy assurance platform, which can be driven by the actual security assessments carried out for different organisations, and thus realise custom cyber security training programmes.
DATAMED S. A.
DataMed SA is an Information Technology company, concentrated on the integration of modern, state-of-the-art electronic health solutions to its clientele. DataMed SA was founded in 1999 as the Healthcare IT specialist, with the vision to improve the quality of healthcare services provision, facilitate data access and contribute to more cost-effective use of available resources.
Our strategy incorporates delivering global, state-of-the-art e-Health solutions for hospitals,primary care physicians, clinics, patients, and the population, to new local or international markets, by bringing together our different leading partners to a superior network.
Through our global network of partners (like IBM, Microsoft, ELADHealth, Better, OTE, Oracle, etc), we are able to offer state-of-the-art integrated Hospital Management Information Systems solutions, fully adjusted and customized to fulfil the special requirements of public and private hospitals in Greece and Cyprus. Our solutions provide fully interoperable Clinical, Laboratory, Radiology Information Systems, combined with ERP and Hospital Analytics – Business Intelligence Systems, based on modern technologies and workflow processes.
INNOVATION TO GROW S.R.L
Innovation To Grow is an innovative SME active in the area of innovation management and digital transformation, supporting customers in developing business models, technology enabled marketing plans and communication strategies for products, services and business relevant experiences.
By applying a decade of experience in innovation management, i2Grow helps define product strategies that maximize the benefits for the end users in both B2C and B2B value proposition types of offer. Based in Milano, since 2009 we support customers in ideate, innovate, implement and communicate Digital Research projects.
AEGIS IT RESEARCH UG
AEGIS IT RESEARCH UG is a research and development company based in Germany developing and managing innovative IT solutions for numerous business sectors.
It is based on a highly effective professional team consisting of talented researchers and top-class IT experts from all over the world. This team empowers the company with a strong, diverse skillset which helps AEGIS offer innovative products and high-tech business solutions to the market.
AEGIS’ main areas of expertise include Digital Forensic Investigations, adaptive Big Data visualization systems, secure embedded platforms, access control and network security systems, privacy preserving systems, enterprise web applications and all the lifecycle of IT systems (design, development, deployment, optimization and maintenance).
SIEMENS is a global powerhouse in electric and electronic industry, a world leader in complex infrastructures solutions and an active provider of sustainable green technologies.
Siemens Corporate Technology (CT) develop hardware and software systems and solutions, and a broad range of services for the entire field of information and communication technologies, acting as main driver of innovation inside Siemens.
SIEMENS CT Romania is a Romanian branch of these activities. CT has an extensive expertise and experience in all areas of software development, working for a large variety of sectors like energy, mobility and industrial manufacturing or services to mention but a few.
Current research capacity and expertise of the department in Brasov (acting inside Siemens SRL, Romanian house company of Siemens) encompasses fields like Data Analytics and Monitoring, Constraint Based Configurations and Schedulers, Complex Event Processing, Remote Diagnostics Systems, Data Acquisition Architectures, Future Internet Technologies, Industrial-grade DevOps, Environment orchestration, Semantic Data Modelling, Data Aggregation, Federated Platforms.
The department acts at the global scale in Siemens Corporate Technology division, core technological house of the corporation. Due to this unique position, the group contributes in the large mesh of knowledge of CT experts, with large access to the EU funded projects where Siemens CT already contributes. From the local group perspective, the expertise offered is centred around some main research cores: Knowledge based systems (with a strong focus on Constraints Based Systems and the mix with Semantic technologies), Event Processing and Event Driven Architectures, Internet of Things in complete stack from device enablement and security, middleware up to predictive analytics, Multi-Agent Systems, Big Data analytics, Cloud Computing and Networking technologies, embedded systems, Intelligent Energy Grid Management or Cities Infrastructures.
EUNOMIA is a consultancy firm, located in Cork (Ireland), specialised in the provision of business and legal consultancy services information technology (IT), including, privacy & data protection (GDPR).
EUNOMIA team is composed of experts with an international background and professional experience gained both in academia and in the private sector, maintaining an extensive network in the ICT domain. All team members have been closely collaborating with interdisciplinary teams and they are well aware of how to approach problems from different standpoints in order to tackle them efficiently.
This holds true when, for example, internal security and privacy tests reveal vulnerabilities that may essentially entail reorganizing internal workflows. EUNOMIA experts are in the position to support an organization in such a situation in understanding problems and technical faults more accurately, utilising data-based decision making in an appropriate manner and to provide guidance for managing data and privacy risks effectively and cost efficiently.
EUNOMIA acknowledges the particular traits of each stakeholder (e.g. SME, large corporations) and customizes the provisioning of its services accordingly, aiming to keep the quality of its services consistently high. EUNOMIA -and EUNOMIA team members- have a growth mindset, making conscious efforts towards deepening the knowledge in the field of law, aiming to amplify the understanding of the associated legal challenges raised by ICT developments, such as AI and 5G networks. Overall, EUNOMIA’s vision is to set long term goals and to focus on the concrete steps needed to materialize them.
This RETENTION-Project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. 965343.
Tel. +30 210 772 3893
Fax +30 210 772 2431